New Vision has secured 3 million euros from Buysse & Partners to expand its network of ophthalmic centers across Belgium.
Target Company Overview
New Vision, founded in 2015, has pioneered a new model for ophthalmic treatments, offering procedures such as cataract surgeries, refractive lens implants, and eyelid corrections. The company treated its first patients in a rented facility in late 2016 and opened its inaugural owned eye clinic in Laakdal in August 2020. New Vision aims to provide high-quality and accessible ophthalmic care outside traditional hospital settings while adhering to international safety standards.
By addressing critical challenges in the healthcare sector, New Vision positions itself as a vital alternative. The company seeks to alleviate the financial pressures on hospitals and the limited availability of operating rooms, allowing ophthalmologists to treat patients at their own pace. Clear reimbursement agreements between doctors, facilities, and patients facilitate this model, thereby attracting attention from both ophthalmologists and hospitals. This innovative approach has led to increased patient inflow, underscoring the demand for timely ophthalmic care.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Belgium
In Belgium, the healthcare industry is undergoing significant transformations, driven by rising demand for specialized services and increasing pressure on hospital operations. With an aging population and growing public health concerns, the need for eff
Similar Deals
Kurma Growth Opportunities, Eurazeo → PanTera
2024
Buysse & Partners
invested in
New Vision
in 2023
in a Growth Equity & Expansion Capital deal
Disclosed details
Transaction Size: $3M